Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.
Take two mins to learn more
Breakthrough technology: Evoralis' microfluidics platform screens millions of enzymes daily—1,000x faster than the competition.
Urgent market demand: Tackling nylon-6/66 recycling in textiles—backed by industry giants like Inditex, H&M, and Veolia.
Built to scale: Screening at TRL7 and scaling enzyme production with CPI—de-risking the path to industrial rollout.
Strong industry pull: Engaged with BMW, BASF, Aquafil.

